Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders
September 01, 2017 07:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced the final approval by the Company’s board of directors of the...
Forward Pharma Obtains Shareholder Approval of the Planned Capital Reduction at the Extraordinary General Meeting
August 02, 2017 16:45 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced the result of the extraordinary general meeting of its...
Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders
July 18, 2017 08:05 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, July 18, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“the Company” or “Forward”) today announced plans to return EUR 19.45 per share amounting to a total of EUR...
Forward Pharma CEO to Present at the JMP Securities 2017 Life Sciences Conference on June 20, 2017
June 14, 2017 08:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 14, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
Forward Pharma CEO to Present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017
June 02, 2017 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, June 02, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
Forward Pharma Appeals the Initial Decision in the U.S. Patent Interference to the Federal Circuit
May 31, 2017 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, May 31, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of the notice of appeal of the PTAB decision that ended...
Forward Pharma CEO to Present at the 42nd Annual Deutsche Bank Health Care Conference on May 4, 2017
May 01, 2017 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, May 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will present...
Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement
May 01, 2017 07:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, May 01, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”) today provided an update on the Company’s strategic focus and related...
Forward Pharma Reports Fourth Quarter and Year End 2016 Financial and Operational Results
April 18, 2017 17:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 18, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward” or the “Company”), today reported financial results for the fourth quarter and year ended...
Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc.
March 31, 2017 18:59 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, March 31, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (FWP) (“Forward Pharma” or the “Company”), a biopharmaceutical company that commenced development in 2005 of FP187, a...